S
Susan L. Morris-Natschke
Researcher at University of North Carolina at Chapel Hill
Publications - 287
Citations - 9762
Susan L. Morris-Natschke is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Cytotoxicity & Camptothecin. The author has an hindex of 48, co-authored 284 publications receiving 8331 citations. Previous affiliations of Susan L. Morris-Natschke include China Medical University (Taiwan) & Shandong University.
Papers
More filters
Journal ArticleDOI
Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV Activity.
Qiang Wang,Qiang Wang,Yujiang Li,Liyun Zheng,Huang Xiaowan,Yanli Wang,Chin Ho Chen,Yung Yi Cheng,Susan L. Morris-Natschke,Kuo Hsiung Lee,Kuo Hsiung Lee +10 more
TL;DR: Among the synthesized hybrids, two compounds were highly effective against HIV, and compounds 10a and 10b showed more potent or equipotent anti-HIV activity but displayed lower cytotoxicity.
Journal ArticleDOI
Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors.
TL;DR: In this paper, a 3D Quantitative Structure-Activity Relationship (SAR) model with high predictability was constructed to facilitate further rational design and development of new potent derivatives.
Journal ArticleDOI
Antitumor agents 281. Design, synthesis, and biological activity of substituted 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogs (ATBO) as potent in vitro anticancer agents
Yizhou Dong,Kyoko Nakagawa-Goto,Chin Yu Lai,Susan L. Morris-Natschke,Kenneth F. Bastow,Kuo Hsiung Lee,Kuo Hsiung Lee +6 more
TL;DR: A novel class of antitumor agents, substituted 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one (ATBO) analogs, evaluated their cytotoxic activity against seven human tumor cell lines from different tissues, and established preliminary structure-activity relationships (SAR).
Journal ArticleDOI
Anti-AIDS agents 84. Synthesis and anti-human immunodeficiency virus (HIV) activity of 2'-monomethyl-4-methyl- and 1'-thia-4-methyl-(3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs.
Shi Qing Xu,Xin Yan,Ying Chen,Peng Xia,Keduo Qian,Donglei Yu,Yi Xia,Zheng Yu Yang,Susan L. Morris-Natschke,Kuo Hsiung Lee,Kuo Hsiung Lee +10 more
TL;DR: The bioassay results suggest that the spatial orientation of the 2'-methyl group in DCK analogs can have important effects on anti-HIV activity of this compound class.
Journal ArticleDOI
Structure-activity relationship for enhancement of paracellular permeability across Caco-2 cell monolayers by 3-alkylamido-2-alkoxypropylphosphocholines.
Hui Ouyang,Susan L. Morris-Natschke,Khalid S. Ishaq,Peter Ward,Dongzhou Liu,Sarah K. Leonard,Dhiren R. Thakker +6 more
TL;DR: Phosphocholines are likely to increase paracellular permeability by modulating the signal transduction pathway initiated by a PLC-catalyzed reaction rather than by physically altering the cell membrane.